Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: The Effect of Dapagliflozin on Patients With Cardiomyopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating dapagliflozin in patients with cardiomyopathy, including acute decompensated heart failure. The study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: May Mohamed Abdalla | Conditions: Acute Decompensated Heart Failure (ADHF) | Phase 4 | Status: RECRUITING